Peripheral Neuropathy in Patients with Acute Leukemia Treated with Vincristine
Abstract
Between December 1993 and December 1994, 46 patients with acute leukemia treated with vincristine were evaluated for the possibilities of peripheral neuropathy. Of the 46 patients, 39 patients had acute lymphoblastic leukemia, and 7 had acute non-lymphoblastic leukemia. All patients had received vincristine; 29 (63%) of the 46 patients had it for 5 - 9 weeks, and 17 (37%) had it for 4 weeks or less. rn 10 (21.7%) patients peripheral neuropathy was detected clinically, and in 35 patients (76%) the neuropathy was detected by electrodiagnostic examination. No evidence of neuropathy was detected in 11 patients. The electrodiagnostic examination was more sensitive than the clinical examination. Pe1ipheral neuropathy, either detected clinically or by means of electromyography, occurred mostly in patients with the dosage of vincristine of 5-20 mg, and the duration of treatment of 5-9 weeks.
References
2. Ouvrier RA, Phil JGM, Pollard JD. Peripheral neuropathy in childhood. ·New York; Raven Press, 1990;8-47.
3. Selawry OS, Hananian J, Buffalo MD. Vincristine treatment of cancer in children. AmJ MedAssoc 1963; 2:367-74.
4 . Heyn. RM, Beatty EC, Hammond D, et al. Vincristine in the treatment of acute leukemia in children. Pediatrics 1966; 38: 82-91.
5. Calabresi P, Parks RE Jr. Chemotherapy in neoplastic disease. In: Goodman and Gilman, eds. The pharmacological basic of therapeutics, 7th ed. News York: Mac Millan, 1985; 1003-25.
6. Clal·k AW, Cohen S, Wissenblatt MJ, Wilson SK. Paraplegy following intrathecal chemotherapy neuropathologic findings and elevation of myelin basic protein. Cancer 1982; 50:47-57.
7. Halm AF, Feasby TE, Gilbert JJ. Paraparesis following intrathecal chemotherapy. Neurology 1983; 33:1032-8.
8. Leventhal BG. The leukemias. In: Behrman RE, Kliegman RM, eds. Nelson book of pediatrics. 14th ed. Philadelphia: Saunders, 1992; 1297-301.
9. Sandler SG, Tobin W, Henderson ES. Vincristine induced neuropathy. Neurology 1969; 19:367-74.
Copyright (c) 2018 Taslim E. Soetomenggolo
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Published 2018-10-30
